Furthermore, the phenotypes resulting from additional nonsense Trp53 mutations targeted in mouse cells, when compared with the distribution of TP53 nonsense mutations in human cancers, suggested that p53 nonsense mutations might have similar consequences in humans and mice [6]. This evidence concerns the gene TP53 and cancer.